Table 1.

Patient characteristics at start of forodesine therapy (n = 8)

Characteristic	Value
Median age, y (range)	62 (51-68)
Males, n (%)	7 (88)
Median absolute lymphocyte count, ×109/L (range)	35.85 (1.4-156.66)
Median serum β2-microglobulin, mg/L (range)	6.45 (3.6-16.3)
Rai stage
I, n (%)	1 (12)
II, n (%)	1 (12)
III, n (%)	1 (12)
IV, n (%)	5 (63)
Median prior therapy, n (range)	5 (1-10)
Fludarabine-refractory, n (%)	5 (63)
ZAP-70–positive, n (%)	5 (63)

ZAP-70 indicates ζ-associated protein 70.